Logo der Universitätsmedizin Mainz

Publikationen 2008

Becht E, Witzsch U, Moll V, Stein R.
Operative Therapie der kongenitalen und erworbenen Penisdeviation mittels Raffplastik.
Aktuelle Urol. 2008 Mar;39(2):153-60.

Bentas W, Jones J, Urbschat A, Tilp U, Probst M, Scheuermann E, Hauser IA, Blaheta RA, Jonas D, Gossmann J.
Effect of procurement-related organ lesions on renal transplant outcome.
Clin Transplant. 2008 Jul-Aug;22(4):411-7.

Brenner W, Greber I, Gudejko-Thiel J, Beitz S, Schneider E, Walenta S, Peters K, Unger R, Thüroff JW.
Migration of renal carcinoma cells is dependent on protein kinase Cdelta via beta1 integrin and focal adhesion kinase.
Int J Oncol. 2008 May;32(5):1125-31.

Fandel T, Pfnür M, Schäfer S, Bacchetti P, Mast F, Corinth C, Ansorge M, Melchior S, Thüroff J, Kirkpatrick C, Lehr HA.
Do we truly see what we think we see? The role of cognitive bias in pathological interpretation.
J Pathol. 2008 Oct;216(2):193-200.

Fichtner J, Stackl W, Thüroff JW.
Radical perineal prostatectomy
Aktuelle Urol. 2008 Sep;39(5):381-94.

Fisch M, Thüroff JW.
Continent cutaneous diversion.
BJU Int. 2008 Nov;102(9 Pt B):1314-9.

Gambhir L, Höller T, Müller M, Schott G, Vogt H, Detlefsen B, Ebert AK, Fisch M, Beaudoin S, Stein R, Boyadjiev SA, Gearhart JP, Rösch W, Utsch B, Boemers TM, Reutter H, Ludwig M.
Epidemiological survey of 214 families with bladder exstrophy-epispadias complex.
J Urol. 2008 Apr;179(4):1539-43.

Gillitzer R, Hampel C, Schede J, Pahernik S, Melchior SW, Thüroff JW.
Manifestation of congenital urethral diverticula in a 57-year-old male.
Urol Int. 2008;81(2):238-40.

Gillitzer R, Hampel C, Wiesner C, Hadaschik B, Thüroff J.
Single-institution experience with primary tumours of the male urethra.
BJU Int. 2008 Apr;101(8):964-8.

Hadaschik BA, Adomat H, Fazli L, Fradet Y, Andersen RJ, Gleave ME, So AI.
Intravesical chemotherapy of high-grade bladder cancer with HTI-286, a synthetic analogue of the marine sponge product hemiasterlin.
Clin Cancer Res. 2008 Mar 1;14(5):1510-8.

Hadaschik BA, Ettinger S, Sowery RD, Zoubeidi A, Andersen RJ, Roberge M, Gleave ME.
Targeting prostate cancer with HTI-286, a synthetic analog of the marine sponge product hemiasterlin.
Int J Cancer. 2008 May15;122(10):2368-76.

Hadaschik BA, Gleave ME.
Antisense Oligonucleotides for the Treatment of Cancer.
Beitrag in: Antisense Drug Technology: principles, strategies, and applications.
Herausgeber: Stanley T. Crooke, CRC Press, Taylor & Francis Group Boca Raton, FL, USA, 2. Aufl. 2008, S.699-720.

Hadaschik BA, Jackson J, Fazli L, Zoubeidi A, Burt HM, Gleave ME, So AI.
Intravesically administered antisense oligonucleotides targeting heat-shock protein-27 inhibit the growth of non-muscle-invasive bladder cancer.
BJU Int. 2008 Aug 5;102(5):610-6.

Hadaschik BA, Paterson RF, Fazli L, Clinkscales RW, Shalaby SW, Chew BH.
Investigation of a Novel Degradable Ureteral Stent in a Porcine Model.
J Urol. 2008 Sep;180(3):1161-6.

Hadaschik BA, ter Borg MG, Jackson J, Sowery RD, So AI, Burt HM, Gleave ME.
Paclitaxel and cisplatin as intravesical agents against non-muscle-invasive bladder cancer.
BJU Int. 2008 Jun;101(11):1347-55.

Hadaschik BA, Zhang K, So AI, Bell JC, Thüroff JW, Rennie PS, Gleave ME.
Oncolytic vesicular stomatitis viruses as intravesical agents against non-muscle-invasive bladder cancer.
Urologe A. 2008 Sep;47(9):1145-51.

Hadaschik BA, Zhang K, So AI, Fazli L, Jia W, Bell JC, Gleave ME, Rennie PS.
Oncolytic vesicular stomatitis viruses are potent agents for intravesical treatment of high-risk bladder cancer.
Cancer Res. 2008 Jun 15;68(12):4506-10.

Hampel C, Thüroff JW.
Perkutane Nephrolitholapraxie.
Aktuelle Uro. 2008 Nov;39(6):471-8; quiz 479.

Jones J, Bentas W, Blaheta RA, Makarevic J, Hudak L, Wedel S, Probst M, Jonas D, Juengel E.
Modulation of adhesion and growth of colon and pancreatic cancer cells by the histone deacetylase inhibitor valproic acid.
Int J Mol Med. 2008 Sep;22(3):293-9.

Jones J, Bentas W., S.W. Melchior
Nierentranplantation beim alten Menschen.
Tx Med 2008, 20:24-26.

Jones J, Otu HH, Grall F, Spentzos D, Can H, Aivado M, Belldegrun AS, Pantuck AJ, Libermann TA.
Proteomic identification of interleukin-2 therapy response in metastatic renal cell cancer.
J Urol. 2008 Feb;179(2):730-6.

Jones J, Pantuck AJ.
Genomics and Proteomics in Renal Cell Carcinoma: Diagnosis, Prognosis and Treatment Selection.
Curr Urol Rep. 2008 Jan;9(1):9-14.

Melchior S., Jones J.
Urologische Komplikationen nach Nierentransplantation.
Tx Med 2008, 20:18-20.

Mugabe C, Hadaschik BA, Kainthan RK, Brooks DE, So AI, Gleave ME, Burt HM.
Paclitaxel incorporated in hydrophobically derivatized hyperbranched polyglycerols for intravesical bladder cancer therapy.
BJU Int. 2009 Apr;103(7):978-86.

Neisius A, Schröder A, Riedmiller H, Brzezinska R, Stein R, Thüroff JW.
Ureter triplex with non-functioning upper pole due to ectopic ureterocele and refluxive third ureter bud: Case report and review of the literature.
Urologe A. 2008 Nov;47(11):1483-6.

Ning H, Lin G, Fandel T, Banie L, Lue TF, Lin CS.
Insulin growth factor signaling mediates neuron-like differentiation of adipose tissue-derived stem cells.
Differentiation. 2008 May;76(5):488-94.

Pahernik S, Roos F, Röhrig B, Wiesner C, Thüroff JW.
Elective nephron sparing surgery for renal cell carcinoma larger than 4 cm.
J Urol. 2008 Jan;179(1):71-4.

Roos FC, Pahernik S, Brenner W, Thüroff JW.
Elective organ-sparing surgery for renal tumors in patients with a normal contralateral kidney : Long-term results.
Urologe A. 2008 Jul;47(7):824-9.

Roos FC, Pahernik S, Elsäßer A, Victor A, Brenner W, Thüroff JW.
Langzeitergebnisse der imperativen organerhaltenden Nierentumorchirugie bei Einzelniere/bilateralen Tumoren.
Urologe A. Jul;47(7):818-23.

Roos FC, Pahernik S, Melchior SW, Thüroff JW.
Renal tumour surgery in elderly patients.
BJU Int. 2008 Sep;102(6):680-3.

Roos FC, Sommer S, Hampel C, Melchior SW, Thüroff JW.
Extraprostatic spindle cell stromal tumor of the prostate: case report.
Urology 2008 Jun;71(6):1226.e13-5.

Salzer A, Wiesner C.
Erweiterte PLND vermindert Staging Errors.
Aktuel Urol 2008; 39 (5): 332.

Sowery RD, Hadaschik BA, So AI, Zoubeidi A, Fazli L, Hurtado-Coll A, Gleave ME.
Clusterin knockdown using the antisense oligonucleotide OGX-011 re-sensitizes docetaxel-refractory prostate cancer PC-3 cells to chemotherapy.
BJU Int. 2008 Aug;102(3):389-97.

Stein R
Editorial Comment on: In vitro Investigations of Tissue-Engineered Multilayered Urothelium Established from Bladder Washings.
Eur Urol 2008; 54 (6): 1421-1422.

Stein R, Albers P.
Korporoplastik bei Induratio penis plastica.
Aktuel Urol 2008;39(2):161-7.

Stein R.
Editorial comment on: in vitro investigations of tissue-engineered multilayered urothelium established from bladder washings.
Eur Urol. 2008 Dec;54(6):1421-2.

Thomas C, Wiesner C, Melchior S, Gillitzer R, Schmidt F, Thüroff JW.
Indications for preoperative prostate biopsy in patients undergoing radical cystoprostatectomy for bladder cancer.
J Urol. 2008 Nov;180(5):1938-41. discussion 1941.

Thüroff JW, Jones J.
Editorial Comment: To laser or not to laser
Aktuel Urol 2008; 39 (5): 321-322.

Thüroff JW.
Organerhaltende Therapie bösartiger urologischer Tumoren.
Urologe A. 2008 Jul;47(7):801-2.

Walter C, Al-Nawas B, Grötz KA, Thomas C, Thüroff JW, Zinser V, Gamm H, Beck J, Wagner W.
Prevalence and Risk Factors of Bisphosphonate-Associated Osteonecrosis of the Jaw in Prostate Cancer Patients with Advanced Disease Treated with Zoledronate.
Eur Urol. 2008 Nov;54(5):1066-72.

Wehler T, Graf C, Biesterfeld S, Brenner W, Schadt J, Gockel I, Berger M, Thüroff JW, Galle P, Moehler M, Schimanski C.
Strong Expression of Chemokine Receptor CXCR4 by Renal Cell Carcinoma Correlates with Advanced Disease.
J Oncol. 2008;2008:626340.

Wiesner C, Nabha SM, Dos Santos EB, Yamamoto H, Meng H, Melchior SW, Bittinger F, Thüroff JW, Vessella RL, Cher ML, Bonfil RD.
C-kit and its ligand stem cell factor: potential contribution to prostate cancer bone metastasis.
Neoplasia. 2008 Sep;10(9):996-1003.

Wiesner C, Thomas C, Salzer A, Gillitzer R, Hampel C, Thüroff JW.
Prevalence of lymph node metastases in non-muscle-invasive bladder cancer : Delay of radical cystectomy and upstaging in the cystectomy specimen as risk factors.
Urologe A. 2008 Sep;47(9):1162-6.

Wöllner J, Rösch W, Stein R, Thüroff JW.
Komplette Urethra duplex mit epispader dorsaler Harnröhre.
Urologe A. 2008 Mar;47(3):342-4.